WuXi Biologics (Cayman) Inc. WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

2269

Peringkat dalam Saham #984
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Harga Saham
$5.77
Kapitalisasi Pasar
$23.74B
Perubahan (1 hari)
-8.38%
Perubahan (1 tahun)
25.13%
Negara
CN
Perdagangan WuXi Biologics (Cayman) Inc. (2269)

Kategori

Healthcare
Riwayat harga saham WuXi Biologics (Cayman) Inc. (2269)
Harga penutupan tertinggi: $6.65 pada 2026-10-01

Harga penutupan terendah: $1.19 pada 2017-06-01
Riwayat harga saham WuXi Biologics (Cayman) Inc. dari 2017 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 17.26%
2025 87.45%
2024 -41.69%
2023 -43.71%
2022 -43.37%
2021 8.58%
2020 173.84%
2019 69.74%
2018 28.79%
2017 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$536.91 25.90%
US
$230.20 757.36%
US
$137.83 -3.78%
AU
$291.76 2.51%
BE
$892.44 9.61%
NL